| |
| |
|
| Insider
Information: |
Thorp Clay |
| Relationship: |
Director |
| City: |
Durham |
| State: |
NC |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
80,215 |
|
|
Indirect Shares
|
8,859,224 |
|
|
| Direct
Value |
$53,084 |
|
|
|
Indirect Value
|
$5,609,409 |
|
|
| Total
Shares |
8,939,439 |
|
|
| Total
Value |
$5,662,493 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 19.7%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Clearside Biomedical, Inc. |
CLSD |
Director |
2023-09-25 |
40,522 |
2023-09-25 |
3,545,040 |
Premium* |
|
|
G1 Therapeutics Inc |
GTHX |
10% Owner |
|
0 |
2017-05-16 |
213,114 |
Premium* |
|
|
Phasebio Pharmaceuticals Inc |
PHAS |
Director |
2023-05-19 |
36,693 |
2023-05-19 |
3,545,040 |
Premium* |
|
|
Vigil Neuroscience, Inc. |
VIGL |
Director |
2022-05-17 |
3,000 |
2022-05-17 |
1,556,030 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
80 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,025 |
|
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
56,023 |
|
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-01 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
112,048 |
|
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
B |
$7.00 |
$5,499,998 |
I/I |
785,714 |
4,262,819 |
2.25 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
S |
$7.00 |
$966 |
I/I |
(138) |
3,477,105 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
OE |
$0.02 |
$955 |
I/I |
43,410 |
3,477,243 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
A |
$0.00 |
$0 |
I/I |
3,321,785 |
3,433,833 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
B |
$7.00 |
$749,994 |
I/I |
107,142 |
1,783,020 |
2.25 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
S |
$7.00 |
$483 |
I/I |
(69) |
1,675,878 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
OE |
$0.02 |
$478 |
I/I |
21,705 |
1,675,947 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2016-06-07 |
4 |
A |
$0.00 |
$0 |
I/I |
1,598,219 |
1,654,242 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-17 |
4 |
S |
$8.92 |
$87,470 |
I/I |
(9,806) |
2,080,364 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-01-17 |
4 |
AS |
$8.92 |
$178,400 |
I/I |
(20,000) |
4,242,819 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-17 |
4 |
S |
$8.92 |
$74,625 |
I/I |
(8,366) |
1,774,654 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-01-18 |
4 |
AS |
$8.64 |
$216,000 |
I/I |
(25,000) |
4,217,819 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-18 |
4 |
S |
$8.64 |
$105,909 |
I/I |
(12,258) |
2,068,106 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-18 |
4 |
S |
$8.64 |
$90,348 |
I/I |
(10,457) |
1,764,197 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-19 |
4 |
S |
$8.22 |
$62,406 |
I/I |
(7,592) |
2,060,514 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
May be part of a 13(d) Group |
– – • |
2017-01-19 |
4 |
S |
$8.22 |
$53,249 |
I/I |
(6,478) |
1,757,719 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-01-19 |
4 |
AS |
$8.23 |
$127,442 |
I/I |
(15,485) |
4,202,334 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-01-20 |
4 |
AS |
$7.77 |
$62,160 |
I/I |
(8,000) |
4,194,334 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-02-15 |
4 |
AS |
$7.64 |
$133,585 |
I/I |
(17,485) |
4,176,849 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-02-16 |
4 |
AS |
$7.58 |
$106,120 |
I/I |
(14,000) |
4,162,849 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-02-17 |
4 |
AS |
$7.54 |
$75,400 |
I/I |
(10,000) |
4,152,849 |
0 |
- |
|
| CLSD |
Clearside Biomedical, Inc... |
Director |
– • • |
2017-03-15 |
4 |
AS |
$6.47 |
$304,090 |
I/I |
(47,000) |
4,078,849 |
0 |
- |
|
80 Records found
|
|
Page 1 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
